secwatch.observer — SEC 8-K summary
======================================

Issuer:     Petros Pharmaceuticals, Inc. (PTPI)
CIK:        0001815903
Form:       8-K
Filed at:   2026-09-30T21:09:31+00:00
Accession:  0001104659-26-112399
Event type: other_material
Sentiment:  negative
Materiality: 1.00
Item codes: 1.03, 2.04, 5.02
LLM model:  deepseek-v4.1-flash:cloud@v2

Petros Pharmaceuticals enters General Assignment for Benefit of Creditors, ceases operations
--------------------------------------------------------------------------------

- On September 30, 2026, Petros Pharmaceuticals entered a General Assignment for the Benefit of Creditors, assigning assets to PT Liquidation, LLC.
- The assignment is a liquidation event; the company ceased substantially all business operations and no longer has ability to continue as a going concern.
- Item 2.04: Assignment triggered defaults/obligations, may make outstanding obligations immediately due and requires immediate redemption of all Series A Convertible Preferred Stock.
- Board resignations effective Sept 30, 2026: Joshua N. Silverman, Bruce T. Bernstein, Wayne R. Walker; Fady Boctor terminated as President/CCO; Robert Weinstein resigned as CAO/PFO/PAO.
- The Company said resignations/termination were not due to disagreement with the Company on operations, policies, or practices.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1815903/000110465926112399/0001104659-26-112399-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1815903/000110465926112399/tm2626722d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-112399

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer